Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a written consent form as required by local guidelines.
- People who are 18 years of age or older at the time of signing the consent form, of any gender.
- People who have been diagnosed with breast cancer confirmed by a core needle biopsy, where the cancer tests negative for HER2 (either by gene testing or protein testing at low levels), and also tests negative for estrogen and progesterone receptors (fewer than 10% of cells showing hormone receptor activity).
- People whose breast cancer has not yet been surgically removed and has not yet been treated, is planned to be treated with systemic therapy before surgery, and meets a specific tumour size and spread category — broadly, a tumour of a certain size with any lymph node involvement but no spread to distant parts of the body (confirm with trial site for exact staging details).
- People who are willing to have a research biopsy taken at the start of the trial, where up to four core samples may be collected.
Who may not be able to join:
- People who are currently pregnant or breastfeeding.
- People who are currently taking part in another clinical trial or using any other experimental treatment.
- People who have any medical condition, past or present treatment, abnormal test results, or other circumstances that the trial doctor believes could put them at risk, affect the trial results, or prevent them from completing the full trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 021 4922687
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the breast cancer microbiome pre- and post-therapy, in patients with early stage TNBC undergoing neoadjuvant systemic therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.